Ultrasound biomicroscopy as decisive examination in resolving special glaucoma cases.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 9972335)

Published in Acta Ophthalmol Scand Suppl on January 01, 1998

Authors

G Marchini1, R Tosi, G Ghilotti, M Bonadimani, L Bonomi

Author Affiliations

1: Eye Clinic, University of Verona.

Articles by these authors

The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet (1996) 3.37

HLA-DQ and T-cell receptor genes in insulin-dependent diabetes mellitus. Cold Spring Harb Symp Quant Biol (1986) 3.15

Immunological dissection of human Ia molecules. J Exp Med (1978) 2.93

Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet (1995) 2.93

The selection of control subjects for case/control analysis of susceptibility to type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1993) 2.63

Human Ia molecules carrying DC1 determinants differ in both alpha- and beta-subunits from Ia molecules carrying DR determinants. Nature (1981) 2.39

Evidence that celiac disease is primarily associated with a DC locus allelic specificity. Clin Immunol Immunopathol (1983) 2.02

The first large population based twin study of coeliac disease. Gut (2002) 1.91

Subsets of human Ia-like molecules defined by monoclonal antibodies. Mol Immunol (1981) 1.87

A critical analysis of the long-term results of trabeculectomy. Am J Ophthalmol (1979) 1.78

Ultrasound biomicroscopic and conventional ultrasonographic study of ocular dimensions in primary angle-closure glaucoma. Ophthalmology (1998) 1.64

Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus. Immunogenetics (1980) 1.48

Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib. Clin Exp Med (2008) 1.47

The genetic control of human Ia alloantigens: a three-loci model derived from the immunochemical analysis of 'supertypic' specificities. Immunol Rev (1982) 1.39

Nucleus viscoexpression compared with other techniques of nucleus removal in extracapsular cataract extraction with capsulorhexis. Ophthalmic Surg (1994) 1.37

Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol (1995) 1.26

Secondary implantation of angle-supported anterior chamber and scleral-fixated posterior chamber intraocular lenses. J Cataract Refract Surg (1996) 1.19

Ultrasound biomicroscopy and intraocular-pressure-lowering mechanisms of deep sclerectomy with reticulated hyaluronic acid implant. J Cataract Refract Surg (2001) 1.18

Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study. Ophthalmologica (1999) 1.16

Choroidal calcification in Bartter syndrome. Am J Ophthalmol (1998) 1.16

Genome search in celiac disease. Am J Hum Genet (1998) 1.14

Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells. Nature (1989) 1.13

Differential tissue distribution and ontogeny of DC-1 and HLA-DR antigens. Immunogenetics (1984) 1.12

Binding of one monoclonal antibody to human Ia molecules can be enhanced by a second monoclonal antibody. Eur J Immunol (1981) 1.11

Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line. J Exp Med (1983) 1.10

Differences in the expression and release of DR, BR, and DQ molecules in human cells treated with recombinant interferon gamma: comparison to other interferons. Hum Immunol (1985) 1.09

Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database. Eur J Cancer (2009) 1.07

A radioimmunoassay typing study of non-DQw2-associated celiac disease. Clin Immunol Immunopathol (1986) 1.06

Ultrasound biomicroscopy and corneal endothelium in Nd:YAG-laser iridotomy. Ophthalmic Surg Lasers (1996) 1.00

Trabeculectomy. Results in the treatment of glaucomas. Ophthalmologica (1973) 0.99

Existence of a genetic risk factor on chromosome 5q in Italian coeliac disease families. Ann Hum Genet (2001) 0.99

Gas tamponade and cyclocryotherapy of a chronic cyclodialysis cleft. Br J Ophthalmol (2009) 0.98

Molecular epidemiology in a cluster of cases of postoperative Pseudomonas aeruginosa endophthalmitis. Clin Infect Dis (1998) 0.97

Mechanism of excretion of a bacterial proteinase: factors controlling accumulation of the extracellular proteinase of a Sarcina strain (Coccus P). J Bacteriol (1971) 0.97

Serological and immunochemical analysis of the products of a single HLA DR-alpha and DR-beta chain gene expressed in a mouse cell line after DNA-mediated cotransformation reveals that the beta chain carries a known supertypic specificity. J Exp Med (1985) 0.96

HLA-DR typing by radioimmunoassay. Transplantation (1980) 0.96

Experimental corticosteroid ocular hypertension in the rabbit. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1978) 0.94

Outflow facility after guanethidine sulfate administration. Arch Ophthalmol (1967) 0.94

Assessment of the specificity of human Ia alloantisera and alloantigens by the use of radioiodinated human Ia antigens. Tissue Antigens (1982) 0.93

HLA-A2-binding peptides cross-react not only within the A2 subgroup but also with other HLA-A-locus allelic products. Hum Immunol (1994) 0.93

The distribution of DR5, MT2, and MB3 specificities on human Ia subsets. Immunogenetics (1983) 0.92

Identification by denaturing high-performance liquid chromatography of numerous polymorphisms in a candidate region for multiple sclerosis susceptibility. Genomics (1999) 0.92

"Silent" alleles at the HLA-C locus. J Immunol (1978) 0.91

Studies of rabbit allotypes by cross-linked antisera. Contemp Top Mol Immunol (1973) 0.90

Detection of complex alleles by direct analysis of DNA heteroduplexes. Immunogenetics (1991) 0.90

Myocilin Gln368stop mutation and advanced age as risk factors for late-onset primary open-angle glaucoma. Arch Ophthalmol (2000) 0.90

The peptide binding specificity of HLA-B27 subtypes. Immunogenetics (1994) 0.89

Effects of timolol maleate on tear flow in human eyes. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1980) 0.88

Italian population yields world's largest twin registry. Nat Med (1997) 0.87

Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci. Infect Immun (1983) 0.87

Strong genetic association between HLA-DR3 and a polymorphic variation in the regulatory region of the HSP70-1 gene. Immunogenetics (1993) 0.87

Two brc-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes. Leukemia (1996) 0.86

A safe blood transfusion procedure for immunization against major histocompatibility complex determinants in man. Transplantation (1978) 0.86

Purification and separation of subsets of human Ia molecules by papain digestion. Immunology (1980) 0.84

A new approach to HLA-DPB1 typing combining DNA heteroduplex analysis with allele-specific amplification and enzyme restriction. Immunogenetics (1992) 0.83

Correlations between polymorphisms at the DNA and at the protein level of DRw52 haplotypes, revealed with a variety of techniques. Hum Immunol (1988) 0.83

Association of responsiveness to the major pollen allergen of Parietaria officinalis with HLA-DRB1* alleles: a multicenter study. Hum Immunol (1996) 0.82

Epidemiology of angle-closure glaucoma. Acta Ophthalmol Scand Suppl (2002) 0.82

Subgrouping of DR4 alleles by DNA heteroduplex analysis. Hum Immunol (1992) 0.82

Linkage analysis of multiple sclerosis with candidate region markers in Sardinian and Continental Italian families. Eur J Hum Genet (1999) 0.82

Further characterization of two "DR supertypic" specificities. Additional evidence that they reside on molecules different from those carrying HLA-DR locus specificities. Hum Immunol (1981) 0.81

Microfingerprinting analysis of human Ia molecules favours a three loci model. Mol Immunol (1983) 0.81

Filtration and complications after trabeculectomy and after phaco-trabeculectomy. Acta Ophthalmol Scand Suppl (1997) 0.81

Anchor residue motifs of HLA class-I-binding peptides analyzed by the direct binding of synthetic peptides to HLA class I alpha chains. Hum Immunol (1993) 0.81

Ultrasonographic findings in endophthalmitis. Acta Ophthalmol Scand (1995) 0.81

Influence of carteolol and timolol on IOP an visual fields in glaucoma: a multi-center, double-masked, prospective study. Eur J Ophthalmol (1993) 0.81

Effects of 0.2% brimonidine on ocular anterior structures. J Ocul Pharmacol Ther (1999) 0.81

An improved model of experimentally induced ocular hypertension in the rabbit. Invest Ophthalmol (1976) 0.81

The peptide-binding specificity of HLA-B27 subtype (B*2705) analyzed by the use of polyalanine model peptides. Hum Immunol (1994) 0.80

Intraocular pressure in myopic anisometropia. Int Ophthalmol (1982) 0.80

Glaucoma and quality of the life. Acta Ophthalmol Scand Suppl (1998) 0.80

Immunochemical analysis of a cell transfected with an HLA-DR gene reveals a new alloantigenic specificity within HLA-DRw52. Eur J Immunol (1986) 0.79

HLA segregation of human T-cell subpopulation markers. Hum Immunol (1981) 0.79

The HLA class I-CML association revisited taking into account the two forms of gene fusion in the Philadelphia chromosome. A multicenter study. Leukemia (1994) 0.79

Radioimmunoassay typing gives a more precise definition of the HLA association of type 1 (insulin-dependent) diabetes. Diabetologia (1986) 0.79

An attempt of identifying MS-associated loci as a follow-up of a genomic linkage study in the Italian population. J Neurovirol (2000) 0.79

Southern blot and microfingerprinting analysis of two DR7 haplotypes. Immunogenetics (1986) 0.79

Preparation of liposomes incorporating membrane components from human lymphoid cells. Tissue Antigens (1979) 0.78

Reassessment of HLA association with celiac disease in special reference to the DP association. Hum Immunol (1990) 0.78

Some rabbit allotypic determinants are isotypes in hare. J Immunol (1973) 0.78

Serologically detectable polymorphism of the HLA-DC alpha-subunit. J Immunol (1984) 0.78

Fas gene polymorphisms are not associated with systemic lupus erythematosus, multiple sclerosis and HIV infection. Dis Markers (1998) 0.78

Does nerve fiber layer thickness correlate with visual field defects in glaucoma? A study with the nerve fiber analyzer. Ophthalmologica (1997) 0.78

Gamma Knife stereotactic radiosurgery for uveal melanoma: clinical results after 2 years. Stereotact Funct Neurosurg (1996) 0.77

An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy. Diabetes (1992) 0.77

High-performance liquid chromatographic analysis of physiological amino acids in human brain tumors by pre-column derivatization with phenylisothiocyanate. J Chromatogr B Biomed Sci Appl (1999) 0.77

Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1979) 0.77

[The morphologic changes in atypical deglutition]. Rev Asoc Odontol Argent (1968) 0.77

HPR perimetry and Humphrey perimetry in glaucomatous children. Doc Ophthalmol (1995) 0.77

HLA supratypes in an Italian population. Immunogenetics (1994) 0.77

Anti-Ia reactivity in sera of untreated patients with active Hodgkin's disease. Clin Immunol Immunopathol (1985) 0.77

Mycotic keratitis by Fusarium moniliforme. Acta Ophthalmol Scand (1995) 0.76

The natural history of an HLA haplotype and its recombinants. Immunogenetics (1998) 0.76

Erythrocyte and platelet fatty acids in retinitis pigmentosa. J Endocrinol Invest (1991) 0.76

Antibody reactivity to HLA classes I and II in sera from patients with hydatidosis. J Infect Dis (1987) 0.76

Exploring myelin basic protein for HLA class I-binding sequences. Eur J Immunol (1994) 0.76